-- Health care stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4%.
Indivior Pharmaceuticals (INDV) shares were up more than 2% after the company said it has entered into a $175 million accelerated share repurchase agreement with Barclays Bank, to be executed under the company's existing $400 million buyback program.
Axsome Therapeutics (AXSM) stock was up more than 3% after the company reported higher Q1 revenue while its loss per share increased.
ADMA Biologics (ADMA) shares were 0.8% higher after the company said it received US Food and Drug Administration approval for the supplemental biologics license application to expand the label of its Asceniv therapy.